Fundraising Foxセルジェンテック株式会社
Chiba, JP · 1 known investors
Find your way into セルジェンテック株式会社
Sign up to see every warm intro you have to セルジェンテック株式会社
- Paths you didn't know you had: your email and LinkedIn already hold routes to the セルジェンテック株式会社 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CellGen Tech develops cell-based medicines for rare and intractable diseases by engineering human adipose cells to produce therapeutic proteins. The company focuses on treating conditions caused by missing or deficient enzymes and proteins, with partnerships involving university medical experts.
Founders & leadership
麻
麻生雅是代表取締役社長 (President & CEO)
MA
Masayoshi Aso
TM
Tetsuya Mishima
YT
Yoshitaka Tanaka
TI
Toshitaka Ii
Investors · 1
Frequently asked questions
- What does セルジェンテック株式会社 do?
- CellGen Tech develops cell-based medicines for rare and intractable diseases by engineering human adipose cells to produce therapeutic proteins. The company focuses on treating conditions caused by missing or deficient enzymes and proteins, with partnerships involving university medical experts.
- Who are セルジェンテック株式会社's investors?
- セルジェンテック株式会社's investors include Medical Incubator Japan K.K..
- Where is セルジェンテック株式会社 headquartered?
- セルジェンテック株式会社 is headquartered in Chiba, JP.